Amritalaya Herbs & Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.30 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 4 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.80 M
as on 16-11-2024
- Revenue 89.85%
(FY 2023)
- Profit -1728.58%
(FY 2023)
- Ebitda 246.90%
(FY 2023)
- Net Worth -29.94%
(FY 2023)
- Total Assets 29.82%
(FY 2023)
About Amritalaya Herbs & Nutraceuticals
The Corporate was formerly known as Amritalaya Herbs & Neutraceuticals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.30 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Avinash Singh and Anjali Jindal serve as directors at the Company.
- CIN/LLPIN
U24230UP2020PTC138405
- Company No.
138405
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Amritalaya Herbs & Nutraceuticals Private Limited offer?
Amritalaya Herbs & Nutraceuticals Private Limited offers a wide range of products and services, including Diabetes Medicine, Digestive System Drugs & Medicines, Anti Ulcer Drugs.
Who are the key members and board of directors at Amritalaya Herbs & Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Singh  | Director | 24-Nov-2020 | Current |
| Anjali Jindal | Director | 24-Nov-2020 | Current |
Financial Performance of Amritalaya Herbs & Nutraceuticals.
Amritalaya Herbs & Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 89.85% increase. The company also saw a substantial fall in profitability, with a 1728.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amritalaya Herbs & Nutraceuticals?
Unlock access to Amritalaya Herbs & Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Jan 2022 | ₹1.80 M | Satisfied |
How Many Employees Work at Amritalaya Herbs & Nutraceuticals?
Amritalaya Herbs & Nutraceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amritalaya Herbs & Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amritalaya Herbs & Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
